6.12
Silo Pharma Inc stock is traded at $6.12, with a volume of 98,679.
It is up +5.34% in the last 24 hours and up +5.24% over the past month.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
See More
Previous Close:
$5.81
Open:
$5.81
24h Volume:
98,679
Relative Volume:
0.38
Market Cap:
$6.64M
Revenue:
$72,100
Net Income/Loss:
$-4.84M
P/E Ratio:
-0.8207
EPS:
-7.4566
Net Cash Flow:
$-3.84M
1W Performance:
-4.97%
1M Performance:
+5.24%
6M Performance:
+6.00%
1Y Performance:
-31.13%
Silo Pharma Inc Stock (SILO) Company Profile
Name
Silo Pharma Inc
Sector
Industry
Phone
(718) 400-9031
Address
677 N. WASHINGTON BLVD, SARASOTA
Compare SILO vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
2.38 | 3.16B | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
6.54 | 425.01M | 52.15M | -21.46M | 0 | -0.4675 |
|
GOODO
Gladstone Commercial Corporation
|
20.26 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
2.909 | 269.09M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DWLD
Davis Select Worldwide ETF
|
46.61 | 0 | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc Stock (SILO) Latest News
Silo Pharma regains compliance with Nasdaq min bid price requirement - TipRanks
Silo Pharma Regains Nasdaq Compliance and Advances PTSD Drug SPC-15 Toward Clinical Trials - Minichart
Silo Pharma Regains Nasdaq Compliance, Stabilizing Listing Status - TipRanks
Silo Pharma regains Nasdaq minimum bid price compliance, ticker SILO - TradingView
Silo Pharma (SILO) restores Nasdaq minimum bid price compliance status - Stock Titan
Silo Pharma (SILO) to vote on director slate, auditor and stock increase at Aug 14 meeting - Stock Titan
Silo Pharma Says it Regained Compliance With Nasdaq's Minimum Bid Price Requirement - marketscreener.com
Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement - TradingView
Silo Pharma clears Nasdaq’s bid-price test; stock stays listed - Stock Titan
Silo Pharma Inc (SILO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Silo Pharma Inc (SILO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Silo Pharma Inc (SILO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Silo Pharma Inc (SILO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Silo Pharma Inc (SILO) Institutional Confidence - TradingKey
Silo Pharma Inc (SILO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Silo Pharma Inc (SILO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SILO PHARMA INC (SILO) Stock Chart - ChartMill
SILO Q4 2023 Earnings: EPS Misses Estimates; Pre-Revenue Biotech Faces Cash Burn ConcernsEarnings Outlook Update - newsline.com
SILO Q4 2023 Earnings: EPS Misses Estimates as Company Advances PipelineDividend Cut Risk - newsline.com
Why Did SILO Stock Soar 85% Today? - Stocktwits
Silo Pharma Implements Reverse Stock Split and Restructures Capital - The Globe and Mail
Silo Pharma Shares Drop Following Implementation of 1-for-15 Reverse Stock Split - Moomoo
Silo Pharma (SILO) completes 1-for-15 reverse stock split and cuts authorized shares - Stock Titan
Silo Pharma Announces 1-for-15 Reverse Stock Split - The Globe and Mail
Silo Pharma announces 1-for-15 reverse stock split effective June 2 - Investing.com UK
Silo Pharma announces 1-for-15 reverse stock split effective June 2 By Investing.com - Investing.com South Africa
Silo Pharma to implement 1-for-15 reverse stock split, issued shares fall to ~1.084M - TradingView
Reverse split shrinks Silo Pharma (NASDAQ: SILO) share count and authorization - Stock Titan
SILO Q4 2023 Earnings: EPS Misses Estimates as Development-Stage Biotech Maintains FocusWeak Earnings Momentum - The Legal Advocate
Silo Pharma (SILO) Holds Near Support as Biotech Stock Edges HigherDealer Delta - newsline.com
Silo Pharma Inc. (SILO) Holds Above $0.40 Support After Modest GainsShort Setup Alerts - newsline.com
Silo Pharma (SILO) Surges 5% as Small-Cap Biotech Recovers From Recent LowsSupply Zone - newsline.com
Silo Pharma Inc. (SILO) Rallies 3.99% as Biotech Sentiment Improves — Key Levels in FocusDebt Free Companies - The Legal Advocate
Silo Pharma Inc. (SILO) Q4 2023 Earnings: Widening Losses as Pre-Revenue Biotech Focuses on Pipeline ProgressProfit Margin Analysis - Newser
SILO Q4 2023 Earnings: Biotech Misses EPS Estimates as Pre‑Revenue Phase ContinuesCrowd Stock Picks - Newser
Silo Pharma Inc. (SILO) Edges Higher as Shares Test Key ResistanceAggressive Growth Picks - Newser
Silo Pharma (SILO) Q4 2023 Results Disappoint: What Investors Should KnowRevenue Miss Report - The Legal Advocate
Silo Pharma (SILO) Q4 2023 Earnings: Miss Sparks ConcernTrending Entry Points - Newser
Silo Pharma (SILO) Stock Analysis: Falls -3.79%, Watching $0.35 2026-05-19NHNL Ratio - The Legal Advocate
Silo Pharma (SILO) Q4 2023 Results Miss Estimates — EPS $-0.36 vs $-0.20Special Dividend Alert - newsline.com
Silo Pharma, Inc. (SILO) Q1 2026 10-Q: Financials, Crypto Asset Holdings, and Business Developments - Minichart
Silo Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Silo Pharma (NASDAQ: SILO) Q1 loss widens as R&D and crypto costs rise - Stock Titan
Silo Pharma Launches Ibogaine-Based TBI Therapeutics Initiative - citybuzz -
Silo Pharma files patent for ibogaine-based TBI treatment By Investing.com - Investing.com Australia
Silo Pharma files patent for ibogaine-based TBI treatment - Investing.com
With no FDA-approved TBI drugs, Silo pursues ibogaine therapy - Stock Titan
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury - ChartMill
Silo Pharma rallies after securing key patent allowance - MSN
SILO Stock Price, Quote & Chart | SILO PHARMA INC (NASDAQ:SILO) - ChartMill
Silo Pharma Inc Stock (SILO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):